Tandem peptide receptor radionuclide therapy using (90)Y/(177)Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

INTRODUCTION: One of the concepts of theranostics in nuclear medicine is peptide receptor radionuclide therapy (PRRT), whereby labeled somatostatin analogs are used for imaging and treating inoperable or disseminated neuroendocrine tumors (NET). AIM: The aim of the study was to determine the therape...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Kunikowska, Jolanta, Zemczak, Anna, Kołodziej, Maciej, Gut, Paweł, Łoń, Izabela, Pawlak, Dariusz, Mikołajczak, Renata, Kamiński, Grzegorz, Ruchała, Marek, Kos-Kudła, Beata, Królicki, Leszek
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7075861/
https://ncbi.nlm.nih.gov/pubmed/31980909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04690-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados